The technology behind CNP Therapeutics originated in the mid-1980s, when Dr. Frank Prato and other scientists at the University of Western Ontario (UWO) and the Lawson Health Research Institute (LHRI) discovered low-power electromagnetic pulseforms that could predictably increase the perception of pain in snails and mice, however, with the result that pain was primarily increased. Their work progressed greatly in 1995 when Dr. Alex Thomas joined the group and developed the CNP pulseform to elicit the opposite response — the reduction of pain in rodents and snails.
Over the next 10 years, Drs. Prato and Thomas received funding from various government organizations to continue research and conduct numerous clinical trials. Over this period, 339 humans were studied, as the research group examined various effects of pulsed electromagnetic fields. After developing a portable unit that was practical for in-home use, the researchers were able to demonstrate a notable reduction in pain for patients suffering from chronic musculoskeletal pain.